Showing results (1251-1260 of 1,339) with videos related to

Sort By:
Pageof 134
Addiction (Abingdon, England)|January 30, 2019
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in EnglandGraham I Harrison, Karen Murray, Roxanne Gore, et al.
Contact Dermatitis|August 27, 2024
Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol®) is rareLivia F Soriano, M M U Chowdhury, Philippa Cousen, et al.
The British Journal of Dermatology|September 13, 2006
Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study groupA M Bryden, H Moseley, S H Ibbotson, et al.
Science (New York, N.Y.)|July 29, 1994
Spatial Organization and Time Dependence of Jupiter's Tropospheric Temperatures, 1980-1993G S Orton, A J Friedson, P A Yanamandra-Fisher, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2008
Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moietiesJames R Corte, Tianan Fang, Donald J P Pinto, et al.
Nature Communications|September 15, 2018
Less absorbed solar energy and more internal heat for JupiterLiming Li, X Jiang, R A West, et al.
Science Signaling|June 29, 2017
Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumorsBin Li, Darren Orton, Leif R Neitzel, et al.
Bioorganic & Medicinal Chemistry|October 22, 2020
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitorsSébastien L Degorce, Anna Aagaard, Rana Anjum, et al.
BMJ (Clinical Research Ed.)|October 10, 2022
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)David A Jolliffe, Hayley Holt, Matthew Greenig, et al.
The Lancet. Respiratory Medicine|December 17, 2022
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard carePallav L Shah, Christopher M Orton, Beatriz Grinsztejn, et al.
Pageof 134